Safety and effectiveness of longer-term phentermine use: Clinical outcomes from an electronic health record cohort, Obesity (2019) Qsymia, DailyMed (2024) Effects of low-dose, controlled-release, phentermine plus topiramate combination on weight and associated comorbidities in overweight and obese adults (CONQUER): a randomised, placebo-controlled, phase 3 trial, The Lancet (2011) Long-term drug treatment for obesity: A systematic and clinical review, JAMA (2014) Lillys Zepbound (tirzepatide) superior to Wegovy (semaglutide) in head-to-head trial showing an average weight loss of 20.2% vs
The same logic that made weight loss drugs a pharmaceutical phenomenon is now being applied to another condition marked by high prevalence, limited treatment options, and deep consumer demand: hair loss
In suspected overdose cases, doctors use the Rumack-Matthew nomogram along with serum acetaminophen levels to predict the likelihood of hepatotoxicity and determine appropriate treatment timing
If you have spent any time inside the longevity or biohacker side of the internet over the past two years, you have heard the opposite story
This makes independent verification of compounding standards difficult